We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

Fund managers haven’t disclosed any holdings of CTSO yet.

CTSO Hedge Fund Activity: Q1 2026 in Review

50 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2026, worth a combined $9.32M — down 14% from $10.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CTSO positions and 7 closed out — a net gain of 3 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $70.6K. The largest seller was Skylands Capital, cutting an estimated $100K.

  • 50 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2026, down from 51 in Q4 2025.
  • Funds reported $9.32M of Cytosorbents Corp stock for Q1 2026, down 14% quarter-over-quarter.
  • 10 funds opened new Cytosorbents Corp positions in Q1 2026 and 7 closed out, a net change of +3 holders.
  • The largest Cytosorbents Corp buyer in Q1 2026 was Geode Capital Management, an estimated $70.6K added.
  • The largest Cytosorbents Corp seller in Q1 2026 was Skylands Capital, an estimated $100K sold.

Based on aggregated 13F filings for Q1 2026.